Evidence of mosaicism in SPAST variant carriers in four French families.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
07 2021
Historique:
received: 13 07 2020
accepted: 24 02 2021
revised: 14 02 2021
pubmed: 8 5 2021
medline: 8 3 2022
entrez: 7 5 2021
Statut: ppublish

Résumé

Hereditary spastic paraplegias (HSP) are heterogeneous disorders, with more than 70 causative genes. Variants in SPAST are the most frequent genetic etiology and are responsible for spastic paraplegia type 4 (SPG4). Age at onset can vary, even between patients from the same family, and incomplete penetrance is described. Somatic mosaicism is extremely rare with only three patients reported in the literature. We report here SPAST mosaic variants in four unrelated patients. We confirm that mosaicism in SPAST is a very rare event with only four identified cases on more than 300 patients with a SPAST variant previously described by our clinical diagnostic laboratory.

Identifiants

pubmed: 33958741
doi: 10.1038/s41431-021-00847-4
pii: 10.1038/s41431-021-00847-4
pmc: PMC8298572
doi:

Substances chimiques

Spastin EC 3.6.4.3
SPAST protein, human EC 5.6.1.1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1158-1163

Informations de copyright

© 2021. The Author(s), under exclusive licence to European Society of Human Genetics.

Références

Eur J Med Genet. 2017 Oct;60(10):548-552
pubmed: 28778789
Brain. 2019 Jul 1;142(7):e31
pubmed: 31157359
J Neurol Sci. 2014 Dec 15;347(1-2):352-5
pubmed: 25315759
Brain. 2015 Sep;138(Pt 9):2471-84
pubmed: 26094131
Neurogenetics. 2007 Aug;8(3):231-3
pubmed: 17597328
Hum Mol Genet. 2000 Mar 1;9(4):637-44
pubmed: 10699187
J Med Genet. 2006 Mar;43(3):259-65
pubmed: 16055926
Brain. 2018 Dec 1;141(12):3331-3342
pubmed: 30476002
Neurol Genet. 2016 Aug 18;2(5):e94
pubmed: 27583304
J Neurol. 2016 Aug;263(8):1604-11
pubmed: 27260292
Neuropediatrics. 2019 Dec;50(6):391-394
pubmed: 31486053
Exp Neurol. 2014 Nov;261:518-39
pubmed: 24954637
J Neurol Sci. 2015 Oct 15;357(1-2):167-72
pubmed: 26208798
Hum Mutat. 2003 Feb;21(2):170
pubmed: 12552568
Lancet. 1983 May 21;1(8334):1151-5
pubmed: 6133167
Eur J Hum Genet. 2017 Nov;25(11):1217-1228
pubmed: 28832565
Ann Neurol. 2016 Apr;79(4):659-72
pubmed: 26991897

Auteurs

Chloé Angelini (C)

Service de Génétique Médicale, CHU Bordeaux, Bordeaux, Bordeaux, France.
Centre de Référence Maladies Rares Neurogénétique, Service de Génétique Médicale, Bordeaux, France.

Cyril Goizet (C)

Service de Génétique Médicale, CHU Bordeaux, Bordeaux, Bordeaux, France.
Centre de Référence Maladies Rares Neurogénétique, Service de Génétique Médicale, Bordeaux, France.
INSERM U1211, laboratoire MRGM, Univ. Bordeaux, Bordeaux, France.

Samia Ait Said (SA)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France.

William Camu (W)

Centre de référence SLA, explorations neurologiques, CHU et Univ Montpellier, Montpellier, France.

Christel Depienne (C)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France.
Sorbonne université, Institut du Cerveau, INSERM U 1127, Paris, France.
Institute of Human Genetics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

Bénédicte Heron (B)

Service de Neurologie Pédiatrique, Hôpital Armand Trousseau-La Roche Guyon, GHUEP, APHP, Paris, France.

Bophara Kol (B)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France.

Marine Guillaud-Bataille (M)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France.

Perrine Pennamen (P)

Service de Génétique Médicale, CHU Bordeaux, Bordeaux, Bordeaux, France.
INSERM U1211, laboratoire MRGM, Univ. Bordeaux, Bordeaux, France.

Caroline Rooryck (C)

Service de Génétique Médicale, CHU Bordeaux, Bordeaux, Bordeaux, France.
INSERM U1211, laboratoire MRGM, Univ. Bordeaux, Bordeaux, France.

Clarisse Scherer-Gagou (C)

Centre National de Référence pour les Maladies Neurogénétiques de l'Adulte, Département de Neurologie, Centre Hospitalier Universitaire d'Angers, Angers, France.

Laurène Tissier (L)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France.

Giovanni Stevanin (G)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France.
Sorbonne université, Institut du Cerveau, INSERM U 1127, Paris, France.
Equipe de neurogénétique, Ecole Pratique des Hautes Etudes (EPHE), PSL Research University, Paris, France.

Eric Leguern (E)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France. eric.leguern@aphp.fr.
Sorbonne université, Institut du Cerveau, INSERM U 1127, Paris, France. eric.leguern@aphp.fr.

Guillaume Banneau (G)

Sorbonne Université, AP-HP, GH Pitié-Salpêtrière, Département de génétique, Paris, France.
Département de Génétique Médicale, Institut Fédératif de Biologie, Hôpital Purpan, Toulouse, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH